Diabetes Care 24:356-361, 2001
© 2001 by the American Diabetes Association, Inc.
Pathophysiology/Complications Original Article |
Renin-Angiotensin System Gene Polymorphisms, Blood Pressure, Dyslipidemia, and Diabetes in Hong Kong Chinese
A significant association of the ACE insertion/deletion polymorphism with type 2 diabetes
G. Neil Thomas, PHD,
Brian Tomlinson, FRCP,
Juliana C.N. Chan, FRCP,
John E. Sanderson, FRCP,
Clive S. Cockram, FRCP and
Julian A.J.H. Critchley, FRCP
From the Divisions of Clinical Pharmacology (G.N.T., B.T., J.C.N.C.,
J.A.J.H.C.), Cardiology (J.E.S.), and Endocrinology (J.C.N.C., C.S.C.),
Department of Medicine and Therapeutics, The Chinese University of Hong Kong,
The Prince of Wales Hospital, Shatin, Hong Kong, China.
Address correspondence and reprint requests to G. Neil Thomas, PhD, Division
of Clinical Pharmacology, Department of Medicine and Therapeutics, The Prince
of Wales Hospital, Shatin, NT, Hong Kong SAR, China. E-mail:
thomas1997{at}cuhk.edu.hk
.
OBJECTIVE In Chinese populations, hypertension is common and
is a major risk factor for cerebrovascular and coronary heart disease,
particularly when associated with diabetes. The clustering of these disorders
and dyslipidemia and obesity is termed the metabolic syndrome and is
increasing in prevalence in the populations of modernizing Asian nations. The
renin-angiotensin system (RAS) helps maintain blood pressure and salt
homeostasis and may play a role in the pathogenesis of aspects of the
metabolic syndrome. We investigated three RAS gene polymorphismsthe ACE
insertion/deletion (I/D), angiotensinogen (AGT) M235T, and angiotensin II type
1 receptor (AT1R) A1166C polymorphismsfor a possible role in
modulating these disorders in 853 Chinese subjects with varying components of
the metabolic syndrome.
RESEARCH DESIGN AND METHODS The three gene polymorphisms of
this crosssectional study were detected using polymerase chain
reactionbased protocols. The genotype frequencies were compared between
the controls (n = 119) and both overlapping and nonoverlapping groups
of patients with type 2 diabetes, hypertension, and dyslipidemia using
2 test. Differences in levels of the biochemical parameters
between the genotypes were determined using analysis of variance.
RESULTS No significant relationship was identified between
these polymorphisms and blood pressure in this population. Although the
AT1RA1166C polymorphism was not associated with any aspect of the
metabolic syndrome examined, there was limited evidence to suggest that the
AGT M235T polymorphism may be associated with cholesterol levels. The ACE I
allele was significantly more frequent in each group comprising subjects with
type 2 diabetes/glucose intolerance (GIT), and the I allele was associated
with higher fasting plasma glucose levels.
CONCLUSIONS These findings suggest that these polymorphisms
are unlikely to be involved in the pathogenesis of hypertension. The ACE I/D
polymorphism was associated with the metabolic syndrome, having a higher
frequency of I allelecontaining genotypes in those groups, but this
appeared to result predominantly from the relationship with type 2
diabetes/GIT in this population of Chinese subjects.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. J Milionis, M. S Kostapanos, K. Vakalis, I. Theodorou, I. Bouba, R. Kalaitzidis, I. Georgiou, M. S Elisaf, and K. C Siamopoulos
Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome
Journal of Renin-Angiotensin-Aldosterone System,
December 1, 2007;
8(4):
181 - 189.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Meirhaeghe, D. Cottel, P. Amouyel, and J. Dallongeville
Association Between Peroxisome Proliferator-Activated Receptor {gamma} Haplotypes and the Metabolic Syndrome in French Men and Women
Diabetes,
October 1, 2005;
54(10):
3043 - 3048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Heimann, M. H. Favarato, F. C. Gozzo, V. Rioli, F. R. Carreno, M. N. Eberlin, E. S. Ferro, J. H. Krege, and J. E. Krieger
ACE gene titration in mice uncovers a new mechanism for ACE on the control of body weight
Physiol Genomics,
January 20, 2005;
20(2):
173 - 182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. N. Thomas, J. W. Lin, W. W.M. Lam, B. Tomlinson, V. Yeung, J. C.N. Chan, R. Liu, and K. S. Wong
Increasing Severity of Cardiovascular Risk Factors With Increasing Middle Cerebral Artery Stenotic Involvement in Type 2 Diabetic Chinese Patients With Asymptomatic Cerebrovascular Disease
Diabetes Care,
May 1, 2004;
27(5):
1121 - 1126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. B. M. Da Cruz, G. Oliveira, M. Taufer, N. F. Leal, C. H. Schwanke, L. Glock, Y. Moriguchi, and E. H. Moriguchi
Angiotensin I-Converting Enzyme Gene Polymorphism in Two Ethnic Groups Living in Brazil's Southern Region: Association With Age
J. Gerontol. A Biol. Sci. Med. Sci.,
September 1, 2003;
58(9):
M851 - 856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Strazzullo, R. Iacone, L. Iacoviello, O. Russo, G. Barba, P. Russo, A. D'Orazio, A. Barbato, F. P. Cappuccio, E. Farinaro, et al.
Genetic Variation in the Renin-Angiotensin System and Abdominal Adiposity in Men: The Olivetti Prospective Heart Study
Ann Intern Med,
January 7, 2003;
138(1):
17 - 23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-T. Tsai, D. Fallin, F.-T. Chiang, J.-J. Hwang, L.-P. Lai, K.-L. Hsu, C.-D. Tseng, C.-S. Liau, and Y.-Z. Tseng
Angiotensinogen Gene Haplotype and Hypertension: Interaction With ACE Gene I Allele
Hypertension,
January 1, 2003;
41(1):
9 - 15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Feng, T. Niu, X. Xu, C. Chen, Q. Li, R. Qian, G. Wang, and X. Xu
Insertion/Deletion Polymorphism of the ACE Gene Is Associated With Type 2 Diabetes
Diabetes,
June 1, 2002;
51(6):
1986 - 1988.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|